Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (36)

2021

  1. Comprehensive NGS panel validation for the identification of actionable alterations in adult solid tumors

    Journal of Personalized Medicine, Vol. 11, Núm. 5

2018

  1. An immunohistochemical score to predict the outcome for oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 47, Núm. 4, pp. 375-381

  2. Prognostic significance of cyclins A2, B1, D1, and E1 and CCND1 numerical aberrations in oral squamous cell carcinomas

    Analytical Cellular Pathology, Vol. 2018

2014

  1. Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers

    International Journal of Oncology, Vol. 45, Núm. 6, pp. 2250-2266

2012

  1. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 41, Núm. 7, pp. 559-567

  2. Family history and breast cancer hormone receptor status in a Spanish cohort

    PLoS ONE, Vol. 7, Núm. 1

2011

  1. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion

    Molecular Cancer Therapeutics, Vol. 10, Núm. 8, pp. 1357-1366

2010

  1. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model

    Arthritis Research and Therapy, Vol. 12, Núm. 6

  2. Reflexiones sobre la patología ocular

    Revista Espanola de Patologia, Vol. 43, Núm. 2, pp. 88-89

2009

  1. Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy

    Journal of Medical Genetics, Vol. 46, Núm. 1, pp. 40-48

  2. Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis

    Histology and Histopathology, Vol. 24, Núm. 6, pp. 675-682

2008

  1. Intestinal clear cell sarcoma with melanocytic differentiation and extraskeletal myxoid chondrosarcoma rearrangement: Report of a case

    International Journal of Surgical Pathology, Vol. 16, Núm. 2, pp. 189-193

  2. Retinoblastoma loss modulates DNA damage response favoring tumor progression

    PLoS ONE, Vol. 3, Núm. 11

2006

  1. HER-2 status determination in breast carcinomas. A practical approach

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 227-236

2005

  1. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: A tissue microarray study

    Oncology Reports, Vol. 14, Núm. 6, pp. 1527-1531

  2. Prolonged survival after liver transplantation for Hodgkin's disease-induced fulminant liver failure

    Hepato-Gastroenterology, Vol. 52, Núm. 61, pp. 217-219

  3. Recovery of Mycobacterium tuberculosis DNA in biopsies of erythema induratum-results in a series of patients using an improved polymerase chain reaction technique [23]

    British Journal of Dermatology

2004

  1. Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease

    Alcoholism: Clinical and Experimental Research, Vol. 28, Núm. 9, pp. 1413-1418

2003

  1. MOC-31/Ep-CAM immunoreactivity in Merkel cells and Merkel cell carcinomas

    Histopathology, Vol. 43, Núm. 5, pp. 480-484

2002

  1. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas

    Regulatory Peptides, Vol. 104, Núm. 1-3, pp. 161-165